Transgenic technology: An overview of approaches useful in surgical research

Surgical Oncology

Volumn 6, Issue 2, 1997, Pages 99-110

  Brenin, D R ^a   Talamonti, M S ^a   Iannaccone, P M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chimera; Embryonic stem cells; Gene transfer; Pronuclear injection; Transgenic

Indexed keywords

DNA;

CHIMERA; GENE CONTROL; GENE MUTATION; GENETIC TRANSFECTION; MEDICAL RESEARCH; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; STEM CELL; TECHNIQUE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; GENETIC TECHNIQUES; MICE; MICE, TRANSGENIC; RATS; RESEARCH DESIGN;

EID: 0031464779     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(97)00010-8     Document Type: Review

References (51)

1. Hogan E., Costantini F. and Lacy E. Manipulating the Mouse Embryo. Cold Spring Harbor, New York, 1986.
2. al Shawi R., Kinnaird J., Burke J. and Bishop J. O. Expression of a foreign gene in a line of transgenic mice is modulated by a chromosomal position effect. Molecular and Cellular Biology 1990, 10, 1192-1198.
3. Keller S. A., Liptay S., Hajra A. and Meisler M. H. Transgene-induced mutation of the murine steel locus. Proceedings of the National Academy of Sciences, U.S.A. 1990, 87, 10019-10022.
4. Gordon J. W., Uehlinger J., Dayani N., Talansky B. E., Gordon H. L., Rudomen G. S. and Neumann P. E. Analysis of the hotfoot (ho) locus by creation of an insertional mutation in a transgenic mouse. Developmental Biology 1990, 137, 349-358.
5. Costantini F., Radice G., Lee J. L., Chada K. K., Perry W. and Son H. J. Insertional mutations in transgenic mice. Progress in Nucleic Acid Research and Molecular Biology 1989, 36, 159-169.
6. Iannaccone P., Zhou X., Khokha M., Boucher D. and Kuehn M. Insertional mutation of a gene involved in growth regulation of the early mouse embryo. Developmental Dynamics 1992, 194, 198-208.
7. Zhou X., Sasaki H., Lowe L., Hogan B. L. and Kuehn M. R. Nodais a novel TGF-β-like gene expressed in the mouse node during gastrulation. Nature 1993, 361, 543-547.
8. Brenin D. and Iannaccone P. Rat embryonic stem cell line RESC-01 βgeo forms chimeras with multiple developmental anomalies. Proceedings of the Federation of the American Society of Experimental Biologists 1995, 3177, A549.
9. Koller B. H. and Smithies O. Altering genes in animals by gene targeting. Annual Reviews in Immunology 1992, 10, 705-730.
10. Iannaccone P. M., Taborn G. U., Garton R. L., Caplice M. D. and Brenin D. R. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Developmental Biology 1994, 163, 288-292.
11. Brenin D. R., Caplice M. D., Taborn G. U., Garton R. L. and Iannaccone P. M. The derivation and characterization of rat embryonic stem cells. Proceedings of the American Association of Cancer Research 1994, 35, 3646.
12. Brenin D. R. and Iannaccone P. M. Rat embryonic stem cells: characterization, chimera production, and evaluation of pluripotency. Proceedings of the Federation of American Society of Experimental Biologists 1994, 3098, A535.
13. Notarianni E., Galli C., Laurie S., Moor R. M. and Evans M. J. Derivation of pluripotent, embryonic cell lines from the pig and sheep. Journal of Reproduction and Fertility 1991, 43(Suppl.), 255-260.
14. Doetschman T., Williams P. and Maeda N. Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Developmental Biology 1988, 127, 224-227.
15. Sukoyan M. A., Golubitsa A. N., Zhelezova A. L., Shilov A. G., Vatolin S. Y., Maximovsky L. P., Andreeva L. E., McWhir J., Pack S. D., Bayborodin S. I. et al. Isolation and cultivation of blastocyst-derived stem cell lines from American mink (Mustela vision). Molecular Reproduction Developments 1992, 33, 418-431.
16. Bradley A., Evans M., Kaufman M. H. and Robertson E. Formation of germ-line chimeras from embryo-derived teratocarcinoma cell lines. Nature 1984, 309, 255-256.
17. Robertson E. J. Teratocarcinomas and Embryonic Stem Cells a Practical Approach. IRL Press, Oxford, 1987.
18. Connelly C. S., Fahl W. E. and Iannaccone P. M. The role of transgenic animals in the analysis of various biological aspects of normal and pathologic states. Experimental Cell Research 1989, 183, 257-276.
19. Iannaccone P. M. and Scarpelli D. G. Exploring pathogenetic mechanisms using transgenic animals. Annals of Medicine 1993, 25, 131-138.
20. Gordon J. W. Production of transgenic mice. Methods in Enzymology 1993, 225, 747-771.
21. Wood S. A., Pascoe W. S., Schmidt C., Kemler R., Evans M. J. and Allen N. D. Simple and efficient production of embryonic stem cell-embryo chimeras by coculture. Proceedings of the National Academy of Sciences, U.S.A. 1993, 90(10), 4582-4585.
22. Nagy A., Gocza E., Diaz E. M., Prideaux V. R., Ivanyi E., Markkula M. and Rossant J. Embryonic stem cells alone are able to support fetal development in the mouse. Developmental Biology 1990, 10(3), 815-821.
23. Wood S. A., Allen N. D., Rossant J., Auerbach A. and Nagy A. Non-injection methods for the production of embryonic stem cell-embryo chimeras. Nature 1993, 365, 87-89.
24. Kuehn M. R. and Stoye J. P. Insertional mutagenesis and mouse development. In Development - The Molecular Genetic Approach, eds. Russo V. E. A., Brody S., Cove D. and Ottolenghi S. Springer, Berlin, 1992, pp. 420-439.
25. van der Putten H., Botteri F. M., Miller A. D., Rosenfeld M. G., Fan H., Evans R. M. and Verma I. M. Efficient insertion of genes into the mouse germ line via retroviral vectors. Proceedings of the National Academy of Sciences, U.S.A. 1985, 82, 6148-6152.
26. Gendron-Maguire M. and Gridley T. Identification of transgenic mice. Methods in Enzymology 1993, 225, 747-771.
27. Overbeek P. A., Aguilar-Cordova E., Hanten G., Schaffner D. A., Patel P., Lebovitz R. M. and Lieberman M. W. Coinjection strategy for visual identification of transgenic mice. Transgenic Research 1991, 1(1), 31-37.
28. Wigle R. M., Sweet R., Sim G. K., Wold B., Pellicer A., Lacy E., Maniatis T., Silverstein S. and Axel R. Transformation of mammalian cells with genes from prokaryotes and eukaryotes. Biotechnology 1992, 24, 444-452.
29. Hoyle G. W., Mercer E. H., Palmiter R. D. and Brinster R. L. Cell-specific expression from the human dopamine beta-hydroxylase promoter in transgenic mice is controlled via a combination of positive and negative regulatory elements. Journal of Neuroscience 1994, 14(5), 2455-2463.
30. Mullins J. J., Peters J. and Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990, 344, 541-544.
31. Palmiter R. D., Brinster R. L., Hammer R. E., Trumbauer M. E., Rosenfeld M. G., Birnberg N. C. and Evans R. M. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Biotechnology 1992, 24, 429-433.
32. Palmiter R. D., Sandgren E. P., Avarbock M. R., Allen D. D. and Brinster R. L. Heterologous introns can enhance expression of transgenes in mice. Proceedings of the National Academy of Sciences, U.S.A. 1991, 88(2), 478-482.
33. Ohkubo H., Kawakami H., Kakehi Y., Takumi T., Arai H., Yokota Y., Iwai M., Tanabe Y., Masu M., Hata J., Iwao H., Okamoto H., Yokoyama M., Nomura T., Katsuki M. and Nakanishi S. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proceedings of the National Academy of Sciences, U.S.A. 1990, 87, 5153-5157.
34. Mansour S. L. Gene targeting in murine embryonic stem cells: introduction of specific alterations into the mammalian genome. GATA 1990, 7(8), 219-227.
35. Thomas K. R., Deng C. and Capecchi M. R. High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Molecular and Cellular Biology 1992, 12(7), 2919-2923.
36. Katsuki M., Sato M., Kimura M., Yakoyama M., Kobayashi K. and Nomura T. Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice. Science 1988, 241, 593-595.
37. Qiao J. H., Xie P. Z., Fishbein M. C., Kreuzer J., Drake T. A., Demer L. L. and Lusis A. J. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arteriosclerosis Thrombosis 1994, 14(9), 1480-1497.
38. Smith J. P., Kasten-Jolly J., Field L. J. and Thomas J. M. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice. Transplantation 1994, 58(3), 324-329.
39. Markmann J. F., Campos L., Bhandoola A., Kim J. I., Desai N. M., Bassiri H., Claytor B. R. and Barker C. F. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Surgery 1994, 116(2), 242-248.
40. Munn S. R. and Marjoribanks C. Current limitations to use of major histocompatibility complex transgenic donors for islet transplantation. Transplantation 1994, 57(5), 760-763.
41. Bassiri H., Markmann J. F., Desai N. M., Kim J. I., Teh H. S. and Barker C. F. Allograft rejection by T cell receptor transgenic mice. Journal of Surgical Research 1993, 54(5), 437-444.
42. Valdivia L. A., Sun H., Rao A. S., Tsugita M., Pan F., Wakizaka Y., Miki T., Demetris A. J., Fung J. J. and Starzl T. E. Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. Transplantation Proceedings 1996, 28(2), 733-734.
43. Li X. and Faustman D. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation 1993, 55(4), 940-946.
44. Bortner D. M. and Rosenberg M. P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Molecular and Cellular Biology 1997, 17(1), 453-459.
45. Tekmal R. R., Ramachandra N., Gubba S., Durgam V. R., Mantione J., Toda K., Shizuta Y. and Dillehay D. L. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities. Cancer Research 1996, 56(14), 3180-3185.
46. Shibata M. A., Maroulakou I. G., Jorcyk C. L., Gold L. G., Ward J. M. and Green J. E. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Research 1996, 56(13), 2998-3003.
47. Martin D. C., Ruther U., Sanchez-Sweatman O. H., Orr F. W. and Khokha R. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogens 1996, 13(3), 569-576.
48. Zhang X. B., Tao K., Urlando C., Shaver-Walker P. and Heddle J. A. Mutagenicity of high fat diets in the colon and small intestine of transgenic mice. Mutagenesis 1996, 11(1), 43-48.
49. Santarelli R., Tzeng Y. J., Zimmermann C., Guhl E. and Graessmann A. SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Oncogene 1996, 12(3), 495-505.
50. Sympson C. J., Bissell M. J. and Werb Z. Mammary gland tumor formation in transgenic mice over-expressing stromelysin - 1. Seminars in Cancer Biology 1995, 6(3), 159-163.
51. Efrat S., Fejer G., Brownlee M. and Horwitz M. S. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proceedings of the National Academy of Sciences, U.S.A. 1995, 92(15), 6947-6951.